AU5275290A - Antitumor preparation obtained following oncolysate treatment - Google Patents

Antitumor preparation obtained following oncolysate treatment

Info

Publication number
AU5275290A
AU5275290A AU52752/90A AU5275290A AU5275290A AU 5275290 A AU5275290 A AU 5275290A AU 52752/90 A AU52752/90 A AU 52752/90A AU 5275290 A AU5275290 A AU 5275290A AU 5275290 A AU5275290 A AU 5275290A
Authority
AU
Australia
Prior art keywords
oncolysate
treatment
obtained following
preparation obtained
antitumor preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU52752/90A
Inventor
James M. Bowen
Ralph S. Freedman
Jim Klostergaard
Eva Lotzova
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System filed Critical University of Texas System
Publication of AU5275290A publication Critical patent/AU5275290A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16133—Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
AU52752/90A 1989-04-11 1990-02-12 Antitumor preparation obtained following oncolysate treatment Abandoned AU5275290A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US33604589A 1989-04-11 1989-04-11
US336045 1989-04-11
US34714089A 1989-05-02 1989-05-02
US347140 1989-05-02

Publications (1)

Publication Number Publication Date
AU5275290A true AU5275290A (en) 1990-11-05

Family

ID=26990014

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52752/90A Abandoned AU5275290A (en) 1989-04-11 1990-02-12 Antitumor preparation obtained following oncolysate treatment

Country Status (2)

Country Link
AU (1) AU5275290A (en)
WO (1) WO1990011765A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6565831B1 (en) 1999-02-24 2003-05-20 Oncolytics Biotech Inc. Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
US6136307A (en) 1997-08-13 2000-10-24 Oncolytics Biotech Inc. Reovirus for the treatment of cellular proliferative disorders
US6110461A (en) 1997-08-13 2000-08-29 Oncolytics Biotech Inc. Reovirus for the treatment of neoplasia
CA2824277C (en) * 2011-01-04 2021-08-31 Jennerex, Inc. Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4108983A (en) * 1976-06-01 1978-08-22 The Wistar Institute Viral oncolysate vaccine for stimulating the immune mechanism of mammals to species-specific tumors

Also Published As

Publication number Publication date
WO1990011765A1 (en) 1990-10-18

Similar Documents

Publication Publication Date Title
AU6897691A (en) Cooker
AU5748990A (en) Venoscope
AU6451490A (en) Medical connector
AU5874690A (en) Octreotide-pamoate
AU627080B2 (en) Sulphonylaminocarbonyltriazolinones
AU4784490A (en) Treatment process
AU623262B2 (en) Hydroxypropylamines
AU6673290A (en) Dipyridodiazepines
AU631622B2 (en) Snow-vehicle
AU6747387A (en) Arylethanolamine derivatives
AU6386390A (en) Therapeutic necleosides
AU623780B2 (en) Chromanderivate
AU4918790A (en) Medicament
AU8269787A (en) Flyslag treatment
AU5782590A (en) Thioxotetrazolines
AU5336690A (en) Leg-guard
AU6627590A (en) Doll-container
AU6839190A (en) Triazolylsulfonamides
AU5275290A (en) Antitumor preparation obtained following oncolysate treatment
AU7984487A (en) Pharmaceutical combination
AU6268590A (en) Aminophosphinates
AU4944090A (en) Cryoelectrosynthesis
AU4958690A (en) Preparation of 2-halofluorobenzene
AU5351590A (en) Dental preparation
AU6255690A (en) Opaliform porcellanite and process for the preparation thereof